Next Article in Journal
Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma
Next Article in Special Issue
Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers
Previous Article in Journal
Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment
Previous Article in Special Issue
Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAFV600E-Specific Inhibitor)
 
 
Article

Article Versions Notes

Cancers 2018, 10(7), 228; https://doi.org/10.3390/cancers10070228
Action Date Notes Link
article xml file uploaded 10 July 2018 06:10 CEST Original file -
article xml uploaded. 10 July 2018 06:10 CEST Update https://www.mdpi.com/2072-6694/10/7/228/xml
article pdf uploaded. 10 July 2018 06:10 CEST Version of Record https://www.mdpi.com/2072-6694/10/7/228/pdf
article supplementary file uploaded. 10 July 2018 06:10 CEST - https://www.mdpi.com/2072-6694/10/7/228#supplementary
article html file updated 10 July 2018 06:11 CEST Original file -
article html file updated 27 July 2018 11:25 CEST Update -
article html file updated 2 August 2018 06:43 CEST Update -
article html file updated 30 March 2019 18:46 CET Update -
article html file updated 15 April 2019 23:02 CEST Update -
article html file updated 30 April 2019 03:43 CEST Update -
article html file updated 5 October 2019 10:23 CEST Update -
article html file updated 10 February 2020 00:41 CET Update -
article html file updated 16 July 2022 22:56 CEST Update https://www.mdpi.com/2072-6694/10/7/228/html
Back to TopTop